Mazars flags CMA interest in Aon/WTW deal

investigations-magnifying-glass

Mazars has forecast that the Competition and Markets Authority will look closely at Aon’s takeover of Willis Towers Watson, as the accountants also predicted the deal could lead to further mergers and acquisitions.

Simon Fitzsimmons, director at Mazars deal advisory, described the takeover as a “blockbuster deal”.

If approved by regulators and shareholders it will see Aon become the largest broker in the world

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

Broker Review of the Year 2024

Brokers were pleased with M&A activity in 2024 but ticked off by disproportionate regulation, capacity exiting the market and artificial intelligence failing to live up to expectations.

Insurance Post’s Christmas Special Podcast

Post content director Jonathan Swift, news editor Scott McGee and Emma Ann Hughes, editor, ditch the usual format of our publication’s award-winning podcast to deliver a holly, jolly Christmas Special.

Biba’s Trudgill on managing change

Trade Voice: Looking ahead to 2025, British Insurance Brokers’ Association CEO Graeme Trudgill says brokers should see enormous changes on the horizon as an opportunity rather than a threat.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here